Target intelligence / Profile preview

RNA, U4 small nuclear 28, pseudogene (RNU4-28P)

Target
RNU4-28P
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

RNU4-28P stands for RNA, U4 small nuclear 28, pseudogene. It is classified as a pseudogene and does not code for a functional protein or RNA involved in cellular processes. Pseudogenes are typically non-functional remnants of genes that have lost their ability to encode functional products due to mutations or genomic rearrangements. There is currently no evidence that RNU4-28P serves as a receptor, enzyme, transporter, or any established drug target. It is not reported in the literature as being involved in disease, as a biomarker, or as pharmacologically actionable. The “U4” small nuclear RNAs (snRNAs) themselves are known to be involved with the spliceosome and pre-mRNA splicing, but the "-28, pseudogene" form (RNU4-28P) does not have a described biological function and is not discussed in therapeutic contexts[1]. Note: There is an unrelated, functionally significant gene termed RNU4-2 (RNA, U4 small nuclear 2), which is an active non-coding RNA and a component of the spliceosome implicated in neurodevelopmental disorders[3][5][6][7]. The "-28, pseudogene" variant specified in this query, however, has no such evidence for function or clinical relevance.

Other names
RNU4-28P

Beyond the preview

Go deeper on RNA, U4 small nuclear 28, pseudogene (RNU4-28P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 28, pseudogene (RNU4-28P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call